Nu Skin Enterprises (NUS) Cost of Revenue (2009 - 2026)

Nu Skin Enterprises (NUS) has 18 years of Cost of Revenue data on file, last reported at $106.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 9.69% year-over-year to $106.1 million; the trailing twelve-month figure through Mar 2026 stood at $418.6 million (down 18.6% YoY), and the FY2025 full-year result was $453.8 million, down 17.53% from the prior year.
• Cost of Revenue improved to $106.1 million in Q1 2026, from $76.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $396.5 million in Q4 2022 to a low of $63.6 million in Q4 2024.
• A 5-year average of $157.3 million and a median of $135.5 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue surged 50.62% in 2022 and slumped 64.92% in 2024, its largest moves.
• Tracing NUS's Cost of Revenue over 5 years: stood at $396.5 million in 2022, then tumbled by 54.27% to $181.3 million in 2023, then tumbled by 64.92% to $63.6 million in 2024, then gained by 20.6% to $76.7 million in 2025, then surged by 38.35% to $106.1 million in 2026.
• Business Quant data shows NUS's Cost of Revenue at $106.1 million in Q1 2026, $76.7 million in Q4 2025, and $107.5 million in Q3 2025.